Clinical Trial Update: Optisure Lead Post Approval Study

View source ↗

Summary

The Optisure lead post-approval study sponsored by Abbott Medical Devices has been terminated, and results have been posted (2025-07-30).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Tachycardia

Drugs mentioned

• Optisure Lead

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Tachycardia, Ventricular | Status: TERMINATED | Results posted: 2025-07-30